Cytokines and toxicity in acetaminophen overdose

Journal of Clinical Pharmacology

Volumn 45, Issue 10, 2005, Pages 1165-1171

  James, Laura P ^a,b   Simpson, Pippa M ^a,b   Farrar, Henry C ^a,b   Kearns, Gregory L ^c,d,e   Wasserman, Gary S ^c,e   Blumer, Jeffrey L ^f,g   Reed, Michael D ^f,g   Sullivan, Janice E ^h   Hinson, Jack A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e CHILDREN S MERCY HOSPITAL   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h KOSAIR CHILDREN'S HOSPITAL   (United States)

Author keywords

Acetaminophen; Cytokines; Monocyte chemoattractant protein 1

Indexed keywords

ACETYLCYSTEINE; ASPARTATE AMINOTRANSFERASE; CYTOKINE; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PARACETAMOL;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG OVERDOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INFANT; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PROTEIN ANALYSIS; PROTHROMBIN TIME; TOXICITY TESTING;

ACETAMINOPHEN; ADOLESCENT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHEMOKINE CCL2; CHILD; CHILD, PRESCHOOL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LINEAR MODELS; MALE; OVERDOSE; PROTHROMBIN TIME;

EID: 25444529963     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270005280296     Document Type: Article

References (32)

1. Blazka ME, Elwell MR, Holladay SD, Wilson RE, Euster MI. Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol. 1996;24:181-189.
2. Blazka ME, Germolec DR, Simeonova P, Bruccoleri A, Pennypacker KR, Luster MI. Acetaminophen-induced hepatotoxicity is associated with early changes in NF-kB and NF-IL6 DNA binding activity. J Inflamm. 1995;47:138-150.
3. James LP, McCullough SS, Lamps LW, Hinson JA. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol Sci. 2003;75:458-467.
4. Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. Faseb J. 2002;16:1227-1236.
5. Dambach DM, Watson LM, Gray KR, Durham SK, Laskin DL. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology. 2002;35:1093-1103.
6. Lawson JA, Farhood A, Hopper RD, Bajt ML, Jaeschke H. The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci. 2000;54:509-516.
7. Bourdi M, Masubuchi Y, Reilly TP, et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology. 2002;35:289-298.
8. Bogdan C, Vodovotz Y, Nathan CK. Macrophage deactivation by interleukin 10. J Exp Med. 1991;174:1549-1555.
9. Masubuchi Y, Bourdi M, Reilly TP, Graf ML, George JW, Pohl LR. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun. 2003;304:207-212.
10. Trepicchio WL, Bozza M, Bouchard P, Dorner AJ. Protective effect of rhIL-11 in a murine model of acetaminophen-induced hepatotoxicity. Toxicol Pathol. 2001;29:242-249.
11. Hogaboam CM, Bone-Larson CL, Steinhauser ML, et al. Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines. Faseb J. 1999;13:1565-1574.
12. Hogaboam CM, Bone-Larson CL, Steinhauser ML, et al. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am J Pathol. 2000;156:1245-1252.
13. James LP, Lamps LW, McCullough S, Hinson JA. Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem Biophys Res Commun. 2003;309:857-863.
14. Hogaboam CM, Simpson KJ, Chensue SW, et al. Macrophage inflammatory protein-2 gene therapy attenuates adenovirus- and acetaminophen-mediated hepatic injury. Gene Ther. 1999;6:573-584.
15. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319:1557-1562.
16. Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22:335-404.
17. James LP, Wells E, Beard RH, Farrar HC. Predictors of outcome after acetaminophen poisoning in children and adolescents. J Pediatr. 2002;140:522-526.
18. Hogaboam CM, Bone-Larson C, Matsukawa A, et al. Therapeutic use of chemokines. Curr Pharm Des. 2000;6:651-663.
19. Zisman DA, Kunkel SL, Strieter RM, et al. MCP-1 protects mice in lethal endotoxemia. J Clin Invest. 1997;99:2832-2836.
20. Ju C, Reilly TP, Bourdi M, et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol. 2002;15:1504-1513.
21. Leifeld L, Dumoulin FL, Purr I, et al. Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol. 2003;199:335-344.
22. Devalaraja MN, McClain CJ, Barve S, Vaddi K, Hill DB. Increased monocyte MCP-1 production in acute alcoholic hepatitis. Cytokine. 1999;11:875-881.
23. Maltby J, Wright S, Bird G, Sheron N. Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology. 1996;24:1156-1160.
24. Afford SC, Fisher NC, Neil DA, et al. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol. 1998;186:82-89.
25. Fisher NC, Neil DA, Williams A, Adams DH. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. Gut. 1999;45:416-420.
26. Muhlbauer M, Bosserhoff AK, Hartmann A, et al. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology. 2003;125:1085-1093.
27. James LP, Farrar HC, Darville TL, et al. Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents. Clin Pharmacol Ther. 2001;70:280-286.
28. Williams AM, Langley PG, Osei-Hwediah J, Wendon JA, Hughes RD. Hyaluronic acid and endothelial damage due to paracetamol-induced hepatotoxicity. Liver Int. 2003;23:110-115.
29. Ren X, Carpenter A, Hogaboam C, Colletti L. Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am J Pathol. 2003;163:563-570.
30. Kerr R, Newsome P, Germain L, et al. Effects of acute liver injury on blood coagulation. J Thromb Haemost. 2003;1:754-759.
31. Bone-Larson CL, Hogaboam CM, Evanhoff H, Strieter RM, Kunkel SL. IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J Immunol. 2001;167:7077-7083.
32. Liu ZX, Govindarajan S, Kaplowitz N. Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology. 2004;127:1760-1774.